QIAGEN N.V.

QGEN · NYSE · SIC 2836: Biological Products, (No Diagnostic Substances)
262
SEC Filings

262 total filings indexed. 262 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001015820
TickerQGEN
ExchangeNYSE
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedP7

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 70308cb308fb74d1749b0f94b06c2797f0b358e75e4da0bf4e2ed08b74c86fc0
parent: root
content hash: ea3035bcbf4fb38daf7005902adc45b4c980a87f6b8f5e8565e34a6af58aec90
signed: 2026-04-13T04:47:04.831Z
sources: 0 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf